Correction: Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia/reperfusion injury - Summary - MDSpire

Correction: Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia/reperfusion injury

  • By

  • Junzhuo Wang

  • Ziwei Chen

  • Qing Dai

  • Jinxuan Zhao

  • Zilun Wei

  • Jiaxin Hu

  • Xuan Sun

  • Jun Xie

  • Biao Xu

  • April 9, 2026

  • 0 min

Share

Objective:

To correct an error in the original article regarding the sourcing of two panels in Fig. 4C.

Key Findings:
  • The statistical analysis and conclusions of the study remain valid and unaffected by the error.
Interpretation:

The correction does not alter the study's findings or implications regarding mesenchymal stem cells and myocardial ischemia/reperfusion injury.

Limitations:
  • The error was a result of oversight in figure assembly, but it did not impact the study's results.
Conclusion:

The original article has been corrected, and the integrity of the research findings is maintained.

Original Source(s)

Correction: Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia/reperfusion injury

  • by Junzhuo Wang, Ziwei Chen, Qing Dai, Jinxuan Zhao, Zilun Wei, Jiaxin Hu, Xuan Sun, Jun Xie, Biao Xu

  • April 9, 2026

Related Content

Understanding the Pathophysiology and Clinical Implications of the Heart-Brain Connection

Serum Urate Goals Tied to Lower CV Risk

Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models